Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3methoxy-4-( methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazol yl)-1,8-naphthyridine-3-carboxylic acid

Details for Australian Patent Application No. 2009335159 (hide)

Owner Sunesis Pharmaceuticals, Inc.

Inventors Sudhakar, Anantha; Subramani, Tamilarasan; Rahuman, Mohamed Sheik Mohamed Mujeebur; Subbiah, Ramar

Agent Henry Hughes Ltd

Pub. Number AU-A-2009335159

PCT Pub. Number WO2010/078294

Priority 61/141,856 31.12.08 US

Filing date 29 December 2009

Wipo publication date 8 July 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/078294 Priority application(s): WO2010/078294

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009335163-Processes for preparing a catalyzed coal particulate

2009335156-Primers and probes for detecting Hepatitis C virus